Aethlon Medical Inc (AEMD.OQ)
AEMD.OQ on NASDAQ Stock Exchange Capital Market
1.03USD
18 Mar 2019
1.03USD
18 Mar 2019
Change (% chg)
$0.02 (+1.98%)
$0.02 (+1.98%)
Prev Close
$1.01
$1.01
Open
$1.02
$1.02
Day's High
$1.04
$1.04
Day's Low
$1.02
$1.02
Volume
15,248
15,248
Avg. Vol
46,629
46,629
52-wk High
$1.83
$1.83
52-wk Low
$0.85
$0.85
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Dec | 0.00 | -0.112 |
| Sep | 0.00 | -0.078 | |
| Jun | 0.15 | -0.065 | |
| FY 2018 | Mar '18 | 0.07 | -0.080 |
| Dec | 0.07 | -0.081 | |
| Sep | 0.00 | -0.144 | |
| Jun | 0.00 | -0.209 | |
| FY 2017 | Mar '17 | 0.00 | -0.217 |
| Dec | 0.00 | -0.152 | |
| Sep | 0.39 | -0.291 | |
| Jun | 0.00 | -0.276 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 1 | 0.10 | 0.10 | 0.10 | -- |
| Quarter Ending Sep-19 | 1 | 0.10 | 0.10 | 0.10 | -- |
| Year Ending Mar-19 | 2 | 0.20 | 0.20 | 0.20 | 0.00 |
| Year Ending Mar-20 | 2 | 0.75 | 1.25 | 0.25 | -- |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 1 | -0.06 | -0.06 | -0.06 | -- |
| Quarter Ending Sep-19 | 1 | -0.06 | -0.06 | -0.06 | -- |
| Year Ending Mar-19 | 2 | -0.34 | -0.33 | -0.34 | -0.30 |
| Year Ending Mar-20 | 2 | -0.26 | -0.23 | -0.30 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 36.12 | 40.53 | |
| P/E High - Last 5 Yrs. | -- | 39.84 | 54.29 | |
| P/E Low - Last 5 Yrs. | -- | 24.25 | 28.91 | |
| Beta | 0.95 | 0.80 | 0.93 | |
| Price to Sales (TTM) | 85.32 | 6.40 | 8.82 | |
| Price to Book (MRQ) | 5.70 | 4.98 | 4.66 | |
| Price to Tangible Book (MRQ) | 5.94 | 8.89 | 6.94 | |
| Price to Cash Flow (TTM) | -- | 24.17 | 28.75 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.00 | 1.47 | |
| Dividend Yield - 5 Year Avg | -- | 1.15 | 1.34 | |
| Dividend 5 Year Growth Rate | -- | 15.57 | -7.18 | |
| Payout Ratio(TTM) | -- | 32.23 | 41.56 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -100.00 | 16.22 | 14.34 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 200.01 | 5.83 | 7.86 | |
| Sales - 5 Yr. Growth Rate | -34.38 | 9.60 | 11.10 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -37.22 | -17.10 | 99.51 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 48.73 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 14.48 | 7.65 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 5.33 | 8.67 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.28 | 2.54 |
| Current Ratio (MRQ) | 2.73 | 2.97 | 3.47 |
| LT Debt to Equity (MRQ) | 0.00 | 20.57 | 13.74 |
| Total Debt to Equity (MRQ) | 28.31 | 26.85 | 17.43 |
| Interest Coverage (TTM) | -8.09 | 27.21 | 40.25 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 58.53 | 53.18 | |
| Gross Margin - 5 Yr. Avg. | -- | 57.97 | 51.33 | |
| EBITD Margin (TTM) | -2,515.66 | -- | -- | |
| EBITD - 5 Yr. Avg | -581.95 | 23.80 | 16.39 | |
| Operating Margin (TTM) | -2,530.37 | 18.06 | 7.59 | |
| Operating Margin - 5 Yr. Avg. | -722.10 | 16.55 | 11.67 | |
| Pre-Tax Margin (TTM) | -2,628.58 | 17.50 | 7.14 | |
| Pre-Tax Margin - 5 Yr. Avg. | -1,006.27 | 16.51 | 16.62 | |
| Net Profit Margin (TTM) | -2,628.58 | 13.08 | 3.22 | |
| Net Profit Margin - 5 Yr. Avg. | -1,006.27 | 11.85 | 11.71 | |
| Effective Tax Rate (TTM) | -- | 24.99 | 22.51 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 27.42 | 23.67 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 37,407 | 30,466,917 | 745,476,794 | |
| Net Income/Employee (TTM) | -983,265 | 3,022,391 | 86,446,517 | |
| Receivable Turnover (TTM) | -- | 4.90 | 4.95 | |
| Inventory Turnover (TTM) | -- | 3.07 | 3.67 | |
| Asset Turnover (TTM) | 0.04 | 0.75 | 0.82 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -110.26 | 9.79 | 9.94 | |
| Return on Assets - 5 Yr. Avg. | -341.02 | 9.03 | 10.85 | |
| Return on Investment (TTM) | -134.08 | 12.60 | 12.30 | |
| Return on Investment - 5 Yr. Avg. | -- | 11.70 | 14.00 | |
| Return on Equity (TTM) | -146.98 | 14.89 | 13.41 | |
| Return on Equity - 5 Yr. Avg. | -- | 15.27 | 15.38 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -61.84 | -41.89 | -34.38 |
| EPS (TTM) % | 50.80 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Aethlon Medical Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -8.18 | -9.71 | 16 | 80 |
| 13 Week | -23.89 | -29.89 | 9 | 85 |
| 26 Week | 0.00 | 2.92 | 64 | 55 |
| 52 Week | -46.84 | -48.26 | 15 | 85 |
| YTD | -39.16 | -45.96 | 2 | 88 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 14.95% |
| # of Holders: | 18 |
| Total Shares Held: | 2,835,430 |
| 3 Mo. Net Change: | -142,068 |
| # New Positions: | 4 |
| # Closed Positions: | 3 |
| # Increased Positions: | 7 |
| # Reduced Positions: | 5 |
| # Net Buyers: | 2 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.